SMN, the Product of the Spinal Muscular Atrophy Gene, Binds Preferentially to Dimethylarginine-Containing Protein Targets
Open Access
- 1 May 2001
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 7 (5) , 1111-1117
- https://doi.org/10.1016/s1097-2765(01)00244-1
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 38 references indexed in Scilit:
- The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm AutoantibodiesJournal of Biological Chemistry, 2000
- Arginine Methylation Inhibits the Binding of Proline-rich Ligands to Src Homology 3, but Not WW, DomainsJournal of Biological Chemistry, 2000
- Gemin4The Journal of cell biology, 2000
- Gemin3The Journal of cell biology, 1999
- Essential Role for the Tudor Domain of SMN in Spliceosomal U snRNP Assembly: Implications for Spinal Muscular AtrophyHuman Molecular Genetics, 1999
- Biochemical Analysis of Myelin Lipids and Proteins in a Model of Methyl Donor Pathway Deficit: Effect of S-AdenosylmethionineExperimental Neurology, 1999
- Regulation of Transcription by a Protein MethyltransferaseScience, 1999
- When Is a Deletion Not a Deletion? When It Is ConvertedAmerican Journal of Human Genetics, 1997
- A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptorThe EMBO Journal, 1997
- Specific Enzymic Methylation of an Arginine in the Experimental Allergic Encephalomyelitis Protein from Human MyelinScience, 1971